Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:amiodarone
|
| gptkbp:approves |
gptkb:FDA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pacerone
|
| gptkbp:ingredients |
C25 H29 I2 N
|
| gptkbp:is_used_for |
treatment of ventricular tachycardia
treatment of ventricular fibrillation |
| gptkbp:manager |
oral
intravenous |
| gptkbp:manufacturer |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:previous_name |
gptkb:amiodarone
|
| gptkbp:side_effect |
liver toxicity
thyroid dysfunction skin discoloration pulmonary toxicity |